Cytiva Completes Doubling of Utah Site’s Liquid Media Production Capacity

July 1, 2026

“On June 25, Cytiva’s Logan Utah operations celebrated an expansion of their facility with a special ribbon cutting event.  The facility not only increased in size from 140,000 square feet to over 240,000 square feet but upgraded operations to more than double their capacity in powder and liquid cell culture media.

The expansion was partially funded by the Biomedical Advanced Research and Development Authority (BARDA).  BARDA focuses on developing medical countermeasures that address public health.  During COVID, the need for cell culture media was acute.  The BARDA funds were allocated to help provide capacity to meet future cell culture media needs in the event of an incidence like COVID in the future.

The Ribbon Cutting ceremony was attended by hundreds of people.  Emcee of the ceremonies was Brad Bingham, VP and General Manager of Cell Culture Media for Cytiva.  Speakers at the event included Christopher Riley, Cytiva CEO & Danaher Exec VP, John Knox, Principal Deputy Assistant Secretary for Preparedness and Response, ASPR, US Health and Human Services, Valerie Marjollet, President of Resins, Filtration and Media for Cytiva, Tara Rosander, Deputy Commissioner Utah Governor’s Office of Economic Development, Senator Chris Wilson, Utah State Senate, and Councilor Jeannie F. Simmonds, Logan City Council.  Others participating in the Ribbon Cutting were Kelvyn Cullimore, CEO of BioUtah, Gary Disbrow, PhD, BARDA Director,  & Ernesto Lopez and Mike Johnson of the Logan City Council.

Also present were members of the Rex Spendlove family.  Rex was the original inventor of the cell media technology that is the basis of the current day Cytiva operations which now employs over 500 people.  In fact, the Logan, Utah area boasts one of the highest percentages of life sciences employees of anywhere in the state.

BioUtah congratulates Cytiva on this significant expansion in support of drug development and responsiveness to BARDA’s need for medical countermeasures when critical needs arise.”

See related article »